186 related articles for article (PubMed ID: 11249656)
21. DNA vaccines against enteric infections.
Herrmann JE
Vaccine; 2006 May; 24(18):3705-8. PubMed ID: 16095769
[TBL] [Abstract][Full Text] [Related]
22. Salivary gland genetic vaccination: a scalable technology for promoting distal mucosal immunity and heightened systemic immune responses.
Tucker SN; Lin K; Stevens S; Scollay R; Bennett MJ; Olson DC
Vaccine; 2004 Jun; 22(19):2500-4. PubMed ID: 15193415
[TBL] [Abstract][Full Text] [Related]
23. Vaccine delivery methods using viral vectors.
Bråve A; Ljungberg K; Wahren B; Liu MA
Mol Pharm; 2007; 4(1):18-32. PubMed ID: 17274663
[TBL] [Abstract][Full Text] [Related]
24. Live bacterial delivery systems for development of mucosal vaccines.
Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
[TBL] [Abstract][Full Text] [Related]
25. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
26. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.
Kasturi SP; Sachaphibulkij K; Roy K
Biomaterials; 2005 Nov; 26(32):6375-85. PubMed ID: 15913771
[TBL] [Abstract][Full Text] [Related]
27. Gene delivery of vaccines for infectious disease.
Clark KR; Johnson PR
Curr Opin Mol Ther; 2001 Aug; 3(4):375-84. PubMed ID: 11525561
[TBL] [Abstract][Full Text] [Related]
28. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development.
Goh SL; Murthy N; Xu M; Fréchet JM
Bioconjug Chem; 2004; 15(3):467-74. PubMed ID: 15149173
[TBL] [Abstract][Full Text] [Related]
29. Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.
Eo SK; Yoon HA; Aleyas AG; Park SO; Han YW; Chae JS; Lee JH; Song HJ; Cho JG
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):451-61. PubMed ID: 16872383
[TBL] [Abstract][Full Text] [Related]
30. The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine.
Wilson KD; de Jong SD; Kazem M; Lall R; Hope MJ; Cullis PR; Tam YK
J Gene Med; 2009 Jan; 11(1):14-25. PubMed ID: 19003796
[TBL] [Abstract][Full Text] [Related]
31. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
Spreng S; Viret JF
Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
[TBL] [Abstract][Full Text] [Related]
32. Gene-based vaccines: recent technical and clinical advances.
Ulmer JB; Wahren B; Liu MA
Trends Mol Med; 2006 May; 12(5):216-22. PubMed ID: 16621717
[TBL] [Abstract][Full Text] [Related]
33. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
Tian J; Yu J; Sun X
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):220-9. PubMed ID: 18722672
[TBL] [Abstract][Full Text] [Related]
34. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
Anderson RJ; Schneider J
Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
[TBL] [Abstract][Full Text] [Related]
35. DNA vaccines for biodefence.
Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
[TBL] [Abstract][Full Text] [Related]
36. Technological advances to increase immunogenicity of DNA vaccines.
Lemieux P
Expert Rev Vaccines; 2002 Jun; 1(1):85-93. PubMed ID: 12908515
[TBL] [Abstract][Full Text] [Related]
37. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
38. Non-viral vector as vaccine carrier.
Chen WC; Huang L
Adv Genet; 2005; 54():315-37. PubMed ID: 16096017
[TBL] [Abstract][Full Text] [Related]
39. Current progress of DNA vaccine studies in humans.
Lu S; Wang S; Grimes-Serrano JM
Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888
[TBL] [Abstract][Full Text] [Related]
40. Bacteria as DNA vaccine carriers for genetic immunization.
Schoen C; Stritzker J; Goebel W; Pilgrim S
Int J Med Microbiol; 2004 Oct; 294(5):319-35. PubMed ID: 15532991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
